Kardium

Diagnostic Equipment · Burnaby, Canada · Founded 2007 · Privately Held (backing)

Developer of medical devices designed to help in the diagnosis and treatment of atrial fibrillation. Kardium is based in Burnaby, Canada and was founded in 2007. It has raised $575 million across 3 recorded rounds; the latest was a $104 million later-stage round in May 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$575.2M
Last round
Later Stage VC
May 2024

Who backs Kardium?

15 investors
InvestorType
Fidelity Management & Research CompanyAsset manager
Qatar Investment AuthorityAsset manager
T. Rowe Price Group—
Fidelity—
Durable Capital PartnersHedge fund
Conconi Growth PartnersFamily office
EckuityGrowth equity
Marin InvestmentsFamily office
Big Basin Partners—
Eventide Asset Management—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kardium investors

15 investors are on record for Kardium, including Fidelity Management & Research Company, Qatar Investment Authority, T. Rowe Price Group and Fidelity. By type, the record holds 2 family offices, 2 asset managers and 1 hedge fund. The later-stage round in May 2024 drew 2 investors.

Free account
More of Kardium with a free account
  • ·The complete investor list: 15 names
  • ·Watch Kardium: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Kardium in diagnostic equipment. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View